120 related articles for article (PubMed ID: 30517995)
1. Retrospective audit of neutropenic fever after chemotherapy: how many patients could benefit from oral antibiotic management?
Poprawski DM; Chan J; Barnes A; Koczwara B
Intern Med J; 2018 Dec; 48(12):1533-1535. PubMed ID: 30517995
[TBL] [Abstract][Full Text] [Related]
2. Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study.
Miedema KG; Tissing WJ; Abbink FC; Ball LM; Michiels EM; van Vliet MJ; de Vries WY; Kamps WA; Norbruis OF; Fiocco M; de Groot-Kruseman HA; van de Wetering MD; de Bont ES
Eur J Cancer; 2016 Jan; 53():16-24. PubMed ID: 26700076
[TBL] [Abstract][Full Text] [Related]
3. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
[TBL] [Abstract][Full Text] [Related]
4. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A
Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
[TBL] [Abstract][Full Text] [Related]
5. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
[TBL] [Abstract][Full Text] [Related]
6. Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
Sebban C; Dussart S; Fuhrmann C; Ghesquieres H; Rodrigues I; Geoffrois L; Devaux Y; Lancry L; Chvetzoff G; Bachelot T; Chelghoum M; Biron P
Support Care Cancer; 2008 Sep; 16(9):1017-23. PubMed ID: 18197434
[TBL] [Abstract][Full Text] [Related]
7. Is parenteral chemotherapy safe in rural hospitals? A prospective audit of neutropenic fever in Albany Hospital, a regional West Australian cancer centre.
Kennedy K; Auret K
Intern Med J; 2017 Feb; 47(2):177-182. PubMed ID: 27753283
[TBL] [Abstract][Full Text] [Related]
8. A comparison of ED and direct admission care of cancer patients with febrile neutropenia.
Owolabi DK; Rowland R; King L; Miller R; Hegde GG; Shang J; Lister J; Venkat A
Am J Emerg Med; 2015 Jul; 33(7):966-9. PubMed ID: 25959844
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
[TBL] [Abstract][Full Text] [Related]
11. Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.
Sung L; Feldman BM; Schwamborn G; Paczesny D; Cochrane A; Greenberg ML; Maloney AM; Hendershot EI; Naqvi A; Barrera M; Llewellyn-Thomas HA
J Clin Oncol; 2004 Oct; 22(19):3922-9. PubMed ID: 15459214
[TBL] [Abstract][Full Text] [Related]
12. Development and implementation of a risk assessment tool for chemotherapy-induced neutropenia.
Donohue R
Oncol Nurs Forum; 2006 Nov; 33(2):347-52. PubMed ID: 16518450
[TBL] [Abstract][Full Text] [Related]
13. Empirical oral antibiotic therapy for low risk febrile cancer patients with neutropenia.
Koh A; Pizzo PA
Cancer Invest; 2002; 20(3):420-33. PubMed ID: 12025236
[TBL] [Abstract][Full Text] [Related]
14. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Colomer R; Perea S; Gómez C; Ruiz A; García-Carbonero R; Cortés-Funes H
Cancer; 1999 Jan; 85(1):213-9. PubMed ID: 9921995
[TBL] [Abstract][Full Text] [Related]
15. Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.
Weycker D; Barron R; Kartashov A; Legg J; Lyman GH
J Oncol Pharm Pract; 2014 Jun; 20(3):190-8. PubMed ID: 23824496
[TBL] [Abstract][Full Text] [Related]
16. Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropenia.
Sung L; Alibhai SM; Ethier MC; Teuffel O; Cheng S; Fisman D; Regier DA
J Clin Epidemiol; 2012 Jun; 65(6):627-34. PubMed ID: 22424607
[TBL] [Abstract][Full Text] [Related]
17. Outpatient therapy for febrile neutropenia.
Innes H; Marshall E
Curr Opin Oncol; 2007 Jul; 19(4):294-8. PubMed ID: 17545790
[TBL] [Abstract][Full Text] [Related]
18. Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice.
Kumar P; Bajpai J; Shetty N; Medekar A; Kurkure PA; Ghadyalpatil N; Gupta S; Noronha V; Kanujia A; Parikh P; Banavali SD
Indian J Cancer; 2014; 51(4):491-5. PubMed ID: 26842174
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of early discharge strategies for neutropenic fever: outcomes of a Victorian organisational readiness assessment and pilot.
Lingaratnam S; Mellerick A; Worth LJ; Green M; Guy S; Kirsa S; Slavin M; Renwick W; Filshie R; Thursky KA
Intern Med J; 2013 Sep; 43(9):979-86. PubMed ID: 23809725
[TBL] [Abstract][Full Text] [Related]
20. Implementation of risk stratified antibiotic therapy for neutropenic fever: what are the risks?
Wierema J; Konecny P; Links M
Intern Med J; 2013 Oct; 43(10):1116-24. PubMed ID: 23869563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
